Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration

European Journal of Pharmacology

Volumn 416, Issue 1-2, 2001, Pages 59-68

  Lockhart, Brian ^a   Bonhomme, Norbert ^a   Roger, Anita ^a   Dorey, Gilbert ^a   Casara, Patrick ^a   Lestage, Pierre ^a  

^a Division of Cerebral Pathology   (France)

Author keywords

Antioxidant; Hypothermia; Ischaemia; Neurodegeneration; S33113

Indexed keywords

6 ETHOXY 2,2 PENTAMETHYLEN 1,2 DIHYDROQUINOLINE; ALLOXAN; DEXTRO METHAMPHETAMINE; DIHYDROQUINOLINE DERIVATIVE; DOPAMINE; ETHOXYQUIN; KAINIC ACID; METHAMPHETAMINE; S 33113; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; BRAIN DEGENERATION; BRAIN MEMBRANE; BRAIN NERVE CELL; CELL DEATH; CELL DEGENERATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOTHERMIA; LETHALITY; LIPID PEROXIDATION; MALE; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; RAT; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

ALLOXAN; ANIMALS; ANTIOXIDANTS; BODY TEMPERATURE; BRAIN ISCHEMIA; CELL SURVIVAL; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HYPERGLYCEMIA; INJECTIONS, INTRAVENTRICULAR; KAINIC ACID; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NERVE DEGENERATION; NEURONS; QUINOLINES; RATS; RATS, WISTAR; RECTUM; SURVIVAL RATE; TERT-BUTYLHYDROPEROXIDE;

EID: 0035937495     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00862-7     Document Type: Article

References (41)

1. The neuropathology of intracerebroventricular t-butylhydroperoxide
2. New aspects of brain oxidative stress induced by tert-butylhydroperoxide
3. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
4. Oxygen-free radicals in rat limbic structures after kainic acid-induced seizures
5. Effects of desferoxamine/manganese complex, a superoxide dismutase-mimic, on kainate-induced pathology in rat brain
6. Comparative metabolism and disposition of ethoxyquin in rat and mouse: II. Metabolism
7. α-phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischaemia
8. α-phenyl-N-tert-butyl-nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia
9. Effect of ethoxyquin on the longevity of C3H mice
10. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57BL/6 mouse
11. Oxidative stress, glutamate, and neurodegenerative disorders
12. Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing?
13. The importance of brain temperature in alterations of the blood-brain barrier during brain ischemia
14. Intraischemic but not postischemic brain hypothermia protects chronically following global forebrain ischemia in rats
15. Brain damage and temperature: Cellular and molecular mechanisms
16. New quinolinic derivatives as centrally active antioxidants
17. Therapeutic modulation of brain temperature: Relevance to ischemic brain injury
18. U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischaemia
19. Free radical theory of ageing: Inhibition of amyloidosis in mice by antioxidants; possible mechanism
20. Inhibition of renal uptake of p-aminohippurate and tetraethylammonium by the antioxidant ethoxyquin in the rat
21. Alloxan-induced diabetes: Evidence for hydroxyl radical as a cytotoxic intermediate
22. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats
23. Detection of hydroxyl radicals in rat striatum during transient focal ischaemia: Possible implication in tissue damage
24. The anti-inflammatory action of some compounds with antioxidant properties
25. Environment, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse
26. Idebenone attenuates neuronal degeneration induced by intrastriatal injections of excitotoxins
27. A new model of bilateral hemispheric ischaemia in the unanaesthetised rat
28. Oxidative processes and antioxidative defence mechanisms in the aging brain
29. Inhibitory effect of the antioxidant ethoxyquin on electron transport in the mitochondrial respiratory chain
30. Antioxidant treatment with phenyl-α-tert-butyl nitrone (PBN) improves the cognitive performance and survival of ageing rats
31. Improved therapeutic window for treatment of histotoxic hypoxia with a free radical spin trap
32. Delayed treatment with a spin trap reduces infarct size in focal ischemia
33. Chronic antioxidant treatment improves the cognitive performance of aged rats
34. Pharmacological manipulation of inflammation in rabbit hydroephrosis: Effects of combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5156 and a PAF antagonist L-659,989
35. The reaction of 1-cyano-1-methylethyl radical with antidegradant ethoxyquin and its aminyl and nitroxide derivatives
36. Some oxidation products of ethoxyquin including those found in autoxidising systems
37. Generation of lipid radicals in the hippocampal extracellular space during kainic acid-induced seizures in rats
38. Protective effects of MCI-186 on cerebral ischaemia: Possible involvement of free radical scavenging and antioxidant actions
39. N-tert-Butyl-alpha-phenylnitrone protects against α,′-Methylene-dioxymethamphetamine-induced depletion of serotonin in rats
40. Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurones